###begin article-title 0
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 47 55 <span type="species:ncbi:9606">patients</span>
Absence of mutations in NR2E1 and SNX3 in five patients with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and related phenotypes
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3</italic>
###xml 184 189 184 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 454 460 454 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 76 83 <span type="species:ncbi:9606">patient</span>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
A disruption of sorting nexin 3 (SNX3) on 6q21 was previously reported in a patient with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and t(6;13)(q21;q12) but no SNX3 mutations were identified in another sporadic case of MMEP, suggesting involvement of another gene. In this work, SNX3 was sequenced in three patients not previously studied for this gene. In addition, we test the hypothesis that mutations in the neighbouring gene NR2E1 may underlie MMEP and related phenotypes.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 393 399 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 77 84 <span type="species:ncbi:9606">patient</span>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 163 170 <span type="species:ncbi:9606">patient</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 635 643 <span type="species:ncbi:9606">patients</span>
Mutation screening was performed in five patients: the t(6;13)(q21;q12) MMEP patient, three additional patients with possible MMEP or a related phenotype, and one patient with oligodactyly, ulnar aplasia, and a t(6;7)(q21;q31.2) translocation. We used sequencing to exclude SNX3 coding mutations in three patients not previously studied for this gene. To test the hypothesis that mutations in NR2E1 may contribute to MMEP or related phenotypes, we sequenced the entire coding region, complete 5' and 3' untranslated regions, consensus splice-sites, and evolutionarily conserved regions including core and proximal promoter in all five patients. Two-hundred and fifty control subjects were genotyped for any candidate mutation.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 71 77 71 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3</italic>
###xml 93 100 <span type="species:ncbi:9606">patient</span>
###xml 206 213 <span type="species:ncbi:9606">patient</span>
We did not detect any synonymous nor nonsynonymous coding mutations of NR2E1 or SNX3. In one patient with possible MMEP, we identified a candidate regulatory mutation that has been reported previously in a patient with microcephaly but was not found in 250 control subjects examined here.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 71 76 71 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 166 172 166 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 175 180 175 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 239 244 <span type="species:ncbi:9606">human</span>
###xml 274 282 <span type="species:ncbi:9606">patients</span>
Our results do not support involvement of coding mutations in NR2E1 or SNX3 in MMEP or related phenotypes; however, we cannot exclude the possibility that regulatory NR2E1 or SNX3 mutations or deletions at this locus may underlie abnormal human cortical development in some patients.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 227 228 227 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 400 401 400 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
The MMEP phenotype and EEC syndrome represent syndromic forms of split-hand/foot malformation (SHFM), which occurs either as an isolated malformation or as a feature of many other conditions with overlapping clinical findings [1]. SHFM can be caused by chromosome rearrangements or single gene mutations and is a genetically heterogeneous malformation with multiple gene loci having been identified [1].
###end p 11
###begin p 12
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3</italic>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 216 224 216 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 380 381 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 390 395 390 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 534 535 534 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 567 572 567 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 652 653 652 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 654 655 654 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 693 698 693 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 269 276 <span type="species:ncbi:9606">patient</span>
###xml 461 468 <span type="species:ncbi:9606">patient</span>
Sorting nexin 3 (SNX3) is ubiquitously expressed and belongs to the sorting nexin family, which is involved in intracellular protein trafficking [2]. Previously, SNX3 was found to be disrupted in its 3rd intron by a de novo balanced translocation t(6;13)(q21;q12) in a patient with MMEP (microcephaly, microphthalmia, ectrodactyly, and prognathism) and severe mental retardation [3]. Thus, SNX3 was initially proposed as a reasonable candidate for MMEP in this patient, who did not harbor any SNX3 mutations on the normal chromosome [3]. However, mutations involving SNX3 were not identified in a sporadic case with possible MMEP and normal karyotype [3,4]. Thus, mutations in a gene close to SNX3 may contribute to MMEP and related phenotypes.
###end p 12
###begin p 13
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1</italic>
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TLX </italic>
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 205 211 205 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 278 284 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr2e1 </italic>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 675 681 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 840 846 840 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 847 848 847 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 849 851 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 599 606 <span type="species:ncbi:9606">patient</span>
###xml 874 881 <span type="species:ncbi:9606">patient</span>
Nuclear receptor 2E1 (NR2E1; previously, TLX [MIM 603849]) is the closest gene to SNX3 (Figure 1) and therefore represents a strong positional candidate that may contribute to the brain phenotype of MMEP. NR2E1 is also a strong functional candidate, given that mice deleted for Nr2e1 present with a complex MMEP-related phenotype that includes forebrain hypoplasia, eye abnormalities, and cognitive impairment [5-7], which is consistent with the brain and eye expression pattern of this gene [8,9]. Further evidence is supported by the possibility that the der(6) breakpoint in the t(6;13)(q21;q12) patient could have created a position effect that altered the expression of NR2E1 resulting in the MMEP phenotype (Figure 1) [3]. Such a hypothesis, however, is difficult to test in light of the predominantly brain-specific transcription of NR2E1 [8,10] and lack of suitable patient material.
###end p 13
###begin p 14
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Schematic drawing of 6q21 demonstrates relative positions of genes flanking SNX3</bold>
###xml 152 159 <span type="species:ncbi:9606">patient</span>
Schematic drawing of 6q21 demonstrates relative positions of genes flanking SNX3. Green bar indicates location of breakpoint within intron 3 of SNX3 in patient with t(6;13)(q21;q12) translocation [3]. Red arrows indicate direction of transcription. Genetic locations of transcriptional start and end sites are from RefSeq genomic assembly NC_000006.10.
###end p 14
###begin p 15
###xml 213 219 213 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 226 230 226 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3</italic>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 674 679 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 103 111 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
###xml 455 462 <span type="species:ncbi:9606">patient</span>
###xml 480 488 <span type="species:ncbi:9606">patients</span>
###xml 539 546 <span type="species:ncbi:9606">patient</span>
###xml 696 704 <span type="species:ncbi:9606">patients</span>
We propose that a gene(s) near the 6q21 translocation may underlie MMEP and related phenotypes in some patients. Here, we test the hypothesis that patients with MMEP or a related phenotype may harbor mutations in NR2E1 and/or SNX3. To test this hypothesis, we sequenced the entire NR2E1 coding region, consensus splice-site regions, complete 5' and 3' untranslated regions and evolutionarily conserved elements including core and proximal promoter in one patient with MMEP, three patients with possible MMEP or related phenotypes, and one patient with oligodactyly, ulnar aplasia, and a t(6;7)(q21;q31.2) translocation [11]. We also sequenced the complete coding regions of SNX3 in three of five patients not previously examined for this gene.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human subjects
###end title 17
###begin p 18
###xml 81 86 <span type="species:ncbi:9606">Child</span>
###xml 212 218 <span type="species:ncbi:9606">Humans</span>
###xml 349 357 <span type="species:ncbi:9606">patients</span>
###xml 394 402 <span type="species:ncbi:9606">Patients</span>
###xml 666 674 <span type="species:ncbi:9606">Patients</span>
Approval for this study was obtained from The University of British Columbia and Child & Family Research Institute. The research followed Canada's Tri-Council Statement on 'Ethical Conduct for Research Involving Humans'. Approval was also obtained through the Institutional Review Board of Self Regional Healthcare (Greenwood, SC). Consent from all patients was obtained for research purposes. Patients were ascertained and examined from five centers: The University of the Witwaterstrand, Johannesburg; The University of Cape Town, South Africa; Cedars-Sinai Medical Center, Los Angeles; Universita Cattolica, Rome; and The University of California, San Francisco. Patients were referred to the Greenwood Genetic Center for molecular research studies on split-hand/foot malformation. Controls were ascertained from the Greenwood Genetic Center.
###end p 18
###begin p 19
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 64 71 <span type="species:ncbi:9606">Patient</span>
###xml 90 97 <span type="species:ncbi:9606">patient</span>
All cases were sporadic and born to non-consanguineous parents. Patient 1 is the original patient with MMEP and t(6;13)(q21;q12) described previously by Viljoen and Smart [12]. This is a 44-year-old Caucasian female with severe mental retardation, congenital microphthalmia causing complete blindness, central cleft lip and palate, ectrodactyly with absence of toes 2-4 on both feet, finger-like thumbs, and a broad, prominent jaw.
###end p 19
###begin p 20
###xml 955 961 955 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP73L </italic>
###xml 974 978 974 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP63</italic>
###xml 1058 1060 1058 1060 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 182 189 <span type="species:ncbi:9606">Patient</span>
Patients 2-4 had normal blood chromosome analyses and were included in this study on the basis of having clinical features that significantly overlapped those of the MMEP phenotype. Patient 2 was felt to have possible MMEP versus an unusual variant of the ectrodactyly-ectodermal dysplasia-clefting (EEC) syndrome and has not been described previously. She is a Hispanic female with congenital microcephaly, bilateral microphthalmia, colobomas of the right iris and retina, left chorioretinal coloboma, left lacrimal duct stenosis, unilateral cleft lip and palate, dysplastic ears, soft tissue syndactyly of fingers 3-4 on the right hand, ectrodactyly of the left foot with a hallux and two digital rays, unilateral mixed versus sensorineural hearing loss requiring a hearing aid, sparse scalp hair and eyebrows, and narrow, deep-set nails. She had a prolonged hospitalization after birth and required gastrostomy tube placement. She had no evidence of a TP73L (previously, TP63, P63) mutation, which is known to be involved in split hand/foot malformation [13].
###end p 20
###begin p 21
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1319 1325 1319 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TP73L </italic>
###xml 1335 1337 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 148 155 <span type="species:ncbi:9606">Patient</span>
###xml 837 844 <span type="species:ncbi:9606">Patient</span>
###xml 1289 1297 <span type="species:ncbi:9606">patients</span>
Patients 3 and 4 were felt to have an unusual variant of the EEC syndrome. A brief summary of their clinical findings was reported previously [13]. Patient 3 is a 10-year-old Caucasian female with microcephaly, bilateral iris colobomas, microphthalmia with significant vision impairment, bilateral ectrodactyly of the hands and feet, unilateral cleft lip, and patchy alopecia of the scalp hair. She required gastrostomy feedings until age 9 due to ongoing problems with feeding, failure to thrive, and severe gastroesophageal reflux. A gastric emptying study revealed delayed emptying with a non-functioning section of the stomach and reverse peristalsis, which resolved with gastric Botox therapy. She has experienced significant dental problems due to ectodermal dysplasia. She attends a regular school program with visual assistance. Patient 4 is an African-American female seen at 3 months of age with congenital microcephaly, congenitally sealed eyelids with small to absent globes, ectrodactyly of the hands and feet, a notch in the upper lip resembling a mild midline cleft, absent scalp hair, underdeveloped eyelashes and eyebrows, underdeveloped nails, minor differences in ear shape, unilateral hearing loss, pelvic kidney, anteriorly placed anus, and tethered spinal cord. Both patients had no evidence of a TP73L mutation [13].
###end p 21
###begin p 22
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient 5 was included in the study on the basis of having a de novo chromosome translocation involving the 6q21 region (t(6;7)(q21;q31.2)) and congenital ulnar ray aplasia. His findings were described previously by Gurrieri et al. [11]. He is a Caucasian male evaluated in the newborn period with congenitally bowed radii, absent ulnae, absence of fingers 3-5 on the right hand, syndactyly of fingers 2-3 and absence of fingers 4-5 on the left hand, and a cyst of the septum pellucidum. He did not have microcephaly, ocular abnormalities, or other features of the MMEP phenotype. We cannot exclude the possibility that breakage at 7q31 may disrupt a gene(s) involved in MMEP.
###end p 22
###begin title 23
DNA amplification and sequencing
###end title 23
###begin p 24
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 936 939 936 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1053 1056 1053 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bsm</italic>
###xml 754 761 <span type="species:ncbi:9606">patient</span>
Sequencing was used to screen for SNX3 coding mutations in all 4 exons as previously described [3]. We sequenced genomic NR2E1 using 20 PCR amplicons that covered the coding regions (1,146 bp), complete 5' and 3' UTRs (1,973 bp), exon-flanking regions including consensus splice-sites (1,719 bp), and evolutionarily conserved regions including the core and proximal promoter (1,528 bp). Polymerase chain reactions (PCR) and sequencing were performed as previously described [14]. Sequences were visually inspected and scored blindly by at least two individuals using either Consed [15] or Sequencher (Gene Codes, Ann Arbor, MI). Every variant identified was confirmed by repeating the PCR and sequencing process. Confirmation of the g.21502T>C change in patient 2 and genotyping of unaffected parents and 250 controls without MMEP or related phenotypes was performed by restriction enzyme digestion of a 505-base pair PCR product using BsmBI. Primers and PCR conditions were as previously reported for 3' UTRb [14]. The alteration created an additional BsmBI site, producing bands of 505, 278, and 227 base pairs in the heterozygous state.
###end p 24
###begin title 25
Results and discussion
###end title 25
###begin title 26
Absence of SNX3 coding mutations in MMEP or related phenotypes
###end title 26
###begin p 27
###xml 43 48 43 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 231 236 231 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1</italic>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
To exclude the role of coding mutations in SNX3 in MMEP or related phenotypes, we sequenced all four coding exons in all patients not previously studied for this gene. No mutations were detected. The absence of coding mutations in SNX3 supports the role of other loci, such as NR2E1, in these disorders. We cannot, however, exclude the role of regulatory SNX3 mutations given that promoter and UTRs were not examined.
###end p 27
###begin title 28
Absence of NR2E1 coding mutations in MMEP or related phenotypes
###end title 28
###begin p 29
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
###xml 265 273 <span type="species:ncbi:9606">patients</span>
To determine whether patients with MMEP or related phenotypes harbor NR2E1 mutations, we sequenced the complete coding region, complete 5' and 3' UTR, consensus splice-sites, and evolutionarily conserved regions including the core and proximal promoter in all five patients. We generated approximately 33.5 kb of sequence data. We did not detect any synonymous nor nonsynonymous coding mutations.
###end p 29
###begin p 30
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 423 424 423 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 78 85 <span type="species:ncbi:9606">patient</span>
###xml 679 686 <span type="species:ncbi:9606">patient</span>
We identified one candidate regulatory mutation in the 3' UTR, g.21502T>C, in patient 2, that was not found in dbSNP (Build 127) [16]. We confirmed this variant by resequencing both strands of DNA. The variant was not predicted to alter binding of neural transcription factors [14]. We genotyped g.21502T>C in the unaffected parents and identified the candidate regulatory mutation in the mother but not the father (Figure 2). In addition, we did not find g.21502T>C in 500 chromosomes from approximately 250 controls without MMEP or related phenotypes. Interestingly, we previously reported the g.21502T>C candidate regulatory mutation (in addition to two other mutations) in a patient with microcephaly and the unaffected father but not in 344 control chromosomes nor in 188 ethnically-diverse chromosomes [14]. Thus, g.21502T>C has so far been identified only in families that present with microcephaly but not in 1032 control chromosomes from subjects that do not present with microcephaly.
###end p 30
###begin p 31
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Genotyping NR2E1 candidate regulatory mutation in patient 2 and family members</bold>
###xml 50 57 <span type="species:ncbi:9606">patient</span>
###xml 134 141 <span type="species:ncbi:9606">patient</span>
Genotyping NR2E1 candidate regulatory mutation in patient 2 and family members. A) DNA sequencing detects g.21502T>C in the 3' UTR of patient 2 but not in unrelated controls. B) Restriction digest detects g.21502T>C in the unaffected mother but not in the unaffected father nor in an unrelated control.
###end p 31
###begin p 32
###xml 220 226 220 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 318 324 318 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr2e1 </italic>
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 445 450 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1</italic>
###xml 639 647 639 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 819 825 819 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nr2e1 </italic>
###xml 829 834 829 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
###xml 654 661 <span type="species:ncbi:9606">patient</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
###xml 941 949 <span type="species:ncbi:9606">patients</span>
One possibility is that the g.21502 T>C is an innocuous substitution that does not contribute to disease but rather represents a rare variant in the general population. An alternative interpretation is that heterozygous NR2E1 mutations may contribute to disease, which is supported by studies in mice heterozygous for Nr2e1 deletions that show premature cortical neurogenesis early in development [17], thereby suggesting dosage sensitivity for NR2E1. The presence of g.21502T>C in an unaffected parent may be due to incomplete penetrance of this variant. Alternatively, g.21502T>C may interact with another susceptibility variant arising de novo in the patient or inherited from the non-g.21502T>C-transmitting parent. Such a mechanism is supported by genetic studies in mice in which double heterozygous mutations at Nr2e1 and Pax6 are shown to enhance cortical phenotypes [18]. It is important to note that the clinical phenotypes of the patients in this study may be attributable to different genetic mechanisms affecting similar developmental pathways.
###end p 32
###begin title 33
Conclusion
###end title 33
###begin p 34
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 224 230 224 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 233 238 233 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 345 351 345 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 354 359 354 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1</italic>
###xml 531 537 531 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 540 545 540 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 701 707 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 850 855 850 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LACE1</italic>
###xml 421 426 <span type="species:ncbi:9606">human</span>
MMEP and related phenotypes represent a spectrum of heterogeneous conditions for which multiple loci may be involved, including NR2E1 and SNX3 on Chromosome 6q21-22 [11,12]. The present study does not support involvement of NR2E1 or SNX3 coding mutations in MMEP or related phenotypes. However, we cannot exclude the possibility that regulatory NR2E1 or SNX3 mutations, such as g.21502T>C of NR2E1, may underlie abnormal human cortical development in some families. In addition, we cannot exclude the possibility that deletions at NR2E1 or SNX3 may underlie MMEP, given that sequencing is unable to distinguish between homozygosity across loci versus large deletions. The lack of obvious mutations in NR2E1 and SNX3 contribute to the genetic complexity underlying this heterogeneous syndrome. Follow-up studies of other positional candidates such as LACE1, would be a next logical undertaking.
###end p 34
###begin title 35
Competing interests
###end title 35
###begin p 36
The author(s) declare that they have no competing interests.
###end p 36
###begin title 37
Authors' contributions
###end title 37
###begin p 38
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
###xml 176 181 176 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3 </italic>
###xml 211 217 211 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR2E1 </italic>
RAK conducted the NR2E1 molecular genetic studies, performed data analysis, and wrote the manuscript. DBE, AS, and CES collected families and provided DNA. CTM carried out the SNX3 sequencing and contributed to NR2E1 genotyping. EMS initiated the study and finalized the analyses as well as the paper. All authors read and approved the final manuscript.
###end p 38
###begin title 39
Pre-publication history
###end title 39
###begin p 40
The pre-publication history for this paper can be accessed here:
###end p 40
###begin p 41

###end p 41
###begin title 42
Acknowledgements
###end title 42
###begin p 43
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SNX3</italic>
###xml 28 36 <span type="species:ncbi:9606">patients</span>
###xml 375 382 <span type="species:ncbi:9606">patient</span>
###xml 750 758 <span type="species:ncbi:9606">Children</span>
###xml 763 768 <span type="species:ncbi:9606">Women</span>
###xml 811 819 <span type="species:ncbi:9606">Children</span>
The authors acknowledge the patients and families who donated their time and blood samples. We thank Dr. Denis L. Viljoen (University of the Witwaterstrand, Johannesburg), Dr. Ronald Smart (University of Cape Town, South Africa), Dr. John M. Graham, Jr. (Cedars-Sinai Medical Center, Los Angeles), and Dr. Fiorella Gurrieri (Universita Cattolica, Rome) for providing us with patient samples. We also thank Tonya Moss for assistance in sequence analyses of SNX3. The authors are grateful to Brett S. Abrahams and Tracey D. Weir (Centre for Molecular Medicine and Therapeutics, Canada) for insight and helpful comments on the manuscript. This work was supported in part by grants from Jack and Doris Brown Foundation and British Columbia Institute for Children's & Women's Health (to RAK); Shriners Hospitals for Children, Grant #8510 (to DBE); South Carolina Department of Disabilities and Special Needs (SCDDSN) (to CES); and Canadian Institutes for Health Research (CIHR), CIHR Research and Development, and Canada Research Chair in Genetics and Behaviour (to EMS).
###end p 43
###begin article-title 44
Pathogenesis of split-hand/split-foot malformation
###end article-title 44
###begin article-title 45
SNX3 regulates endosomal function through its PX-domain-mediated interaction with PtdIns(3)P
###end article-title 45
###begin article-title 46
###xml 41 48 <span type="species:ncbi:9606">patient</span>
Sorting nexin 3 (SNX3) is disrupted in a patient with a translocation t(6;13)(q21;q12) and microcephaly, microphthalmia, ectrodactyly, prognathism (MMEP) phenotype
###end article-title 46
###begin article-title 47
A second case of microcephaly, microphthalmia, ectrodactyly (split-foot) and prognathism (MMEP)
###end article-title 47
###begin article-title 48
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
Fierce: a new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background-dependent
###end article-title 48
###begin article-title 49
Loss of the tailless gene affects forebrain development and emotional behavior
###end article-title 49
###begin article-title 50
###xml 107 111 <span type="species:ncbi:10090">mice</span>
Unexpected embryonic stem (ES) cell mutations represent a concern in gene targeting: lessons from "fierce" mice
###end article-title 50
###begin article-title 51
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 27 37 <span type="species:ncbi:7227">Drosophila</span>
###xml 122 127 <span type="species:ncbi:9606">human</span>
The human homologue of the Drosophila tailless gene (TLX): Characterization and mapping to a region of common deletion in human lymphoid leukemia on chromosome 6q21
###end article-title 51
###begin article-title 52
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain
###end article-title 52
###begin article-title 53
###xml 44 49 <span type="species:ncbi:9606">Human</span>
Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies
###end article-title 53
###begin article-title 54
###xml 23 29 <span type="species:ncbi:9606">infant</span>
Ulnar ray defect in an infant with a 6q21;7q31.2 translocation: further evidence for the existence of a limb defect gene in 6q21
###end article-title 54
###begin article-title 55
Split-foot anomaly, microphthalmia, cleft-lip and cleft-palate, and mental retardation associated with a chromosome 6;13 translocation
###end article-title 55
###begin article-title 56
P63 mutations are not a major cause of non-syndromic split hand/foot malformation
###end article-title 56
###begin article-title 57
###xml 84 90 <span type="species:ncbi:9606">humans</span>
Mutation and evolutionary analyses identify NR2E1-candidate-regulatory mutations in humans with severe cortical malformations
###end article-title 57
###begin article-title 58
Consed: a graphical tool for sequence finishing
###end article-title 58
###begin article-title 59
dbSNP
###end article-title 59
###begin article-title 60
The Tlx Gene Regulates the Timing of Neurogenesis in the Cortex
###end article-title 60
###begin article-title 61
###xml 97 102 <span type="species:ncbi:10090">mouse</span>
Tlx and Pax6 co-operate genetically to establish the pallio-subpallial boundary in the embryonic mouse telencephalon
###end article-title 61

